Brief Description
Applying antisense oligonucleotide technology to target coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.
Inventors
Anders Naar, Sakari Kauppinen
Company Founders
Anders Naar (UC Berkeley, Ph.D. ’95, Molecular Pathology)
Timeline
- 2021. Company founded